Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigation of brain volume changes associated with aging: Results from the fourth research on osteoarthritis/osteoporosis against disability survey.
Nakajima K, Ogawa A, Kodama H, Shirokoshi T, Osada T, Konishi S, Horii C, Oshima Y, Iidaka T, Muraki S, Oka H, Kawaguchi H, Akune T, Hashizume H, Yamada H, Yoshida M, Nakamura K, Shojima M, Tanaka S, Yoshimura N. Nakajima K, et al. Among authors: kodama h. Geriatr Gerontol Int. 2025 Jan 5. doi: 10.1111/ggi.15033. Online ahead of print. Geriatr Gerontol Int. 2025. PMID: 39757113
The utility of customised tissue probability maps and templates for patients with idiopathic normal pressure hydrocephalus: a computational anatomy toolbox (CAT12) study.
Kanno S, Liu J, Kawamura A, Ota S, Kawakami N, Iseki C, Kakinuma K, Matsubara S, Katsuse K, Sato K, Takeuchi T, Tanaka Y, Kodama H, Nagasaka T, Sai M, Odagiri H, Saito M, Takanami K, Mugikura S, Suzuki K. Kanno S, et al. Among authors: kodama h. Fluids Barriers CNS. 2024 Dec 30;21(1):108. doi: 10.1186/s12987-024-00611-y. Fluids Barriers CNS. 2024. PMID: 39736638 Free PMC article.
Randomized, multicenter, active-controlled open-label study of NPC-25, zinc histidine hydrate, (non-inferiority to NOBELZIN™, zinc acetate dihydrate) for patients with hypozincemia.
Asaoka D, Ishihara T, Ezoe S, Hamada I, Kitamura M, Uchino K, Arai K, Kanno Y, Kodama H. Asaoka D, et al. Among authors: kodama h. J Trace Elem Med Biol. 2024 Nov 21;87:127558. doi: 10.1016/j.jtemb.2024.127558. Online ahead of print. J Trace Elem Med Biol. 2024. PMID: 39705879
Computed Tomography-guided Puncture: Preprocedural Preparation, Technical Tips, and Radioprotection.
Takaki H, Kobayashi K, Kako Y, Kodama H, Ogasawara A, Takahagi M, Taniguchi J, Matsuda K, Hatano M, Kikuchi K, Hagihara Y, Matsumoto K, Minami T, Yamakado K. Takaki H, et al. Among authors: kodama h. Interv Radiol (Higashimatsuyama). 2024 Jun 3;9(3):86-91. doi: 10.22575/interventionalradiology.2023-0034. eCollection 2024 Nov 1. Interv Radiol (Higashimatsuyama). 2024. PMID: 39559812 Free PMC article. Review.
Efficacy of subsequent treatment for unresectable locally-advanced non-small cell lung cancer after relapse of concurrent chemoradiotherapy with durvalumab consolidation therapy: A single-center retrospective study.
Nishibori Y, Kenmotsu H, Ando K, Tonsho A, Matsuda S, Morita M, Sekikawa M, Doshita K, Morikawa N, Miura K, Kodama H, Yabe M, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Harada H, Takahashi T. Nishibori Y, et al. Among authors: kodama h. Cancer Treat Res Commun. 2024;41:100849. doi: 10.1016/j.ctarc.2024.100849. Epub 2024 Nov 8. Cancer Treat Res Commun. 2024. PMID: 39536390 Free article.
Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance status.
Nakashima K, Kodama H, Murakami H, Takahashi T, Kawakado K, Yanagawa T, Kitani K, Hottta T, Abe M, Hamai K, Tanimoto T, Ishikawa N, Tamura T, Kuyama S, Isobe T, Tsubata Y. Nakashima K, et al. Among authors: kodama h. Respir Investig. 2024 Nov;62(6):1137-1141. doi: 10.1016/j.resinv.2024.09.010. Epub 2024 Oct 3. Respir Investig. 2024. PMID: 39366122 Free article.
1,441 results